0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sheep and Goat Vaccines Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-7K14397
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Sheep and Goat Vaccines Market Research Report 2023
BUY CHAPTERS

Global Sheep and Goat Vaccines Market Research Report 2025

Code: QYRE-Auto-7K14397
Report
May 2025
Pages:96
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sheep and Goat Vaccines Market Size

The global market for Sheep and Goat Vaccines was valued at US$ 1151 million in the year 2024 and is projected to reach a revised size of US$ 1802 million by 2031, growing at a CAGR of 6.7% during the forecast period.

Sheep and Goat Vaccines Market

Sheep and Goat Vaccines Market

Sheep and goat vaccines are vaccines that are specifically designed for use in sheep and goats to prevent various diseases that can affect these animals. Some of the commonly used sheep and goat vaccines include those for diseases such as Clostridial diseases like Tetanus and Pulpy Kidney, Foot Rot, Pasteurella, and Contagious Ecthyma (Orf). These vaccines are typically administered via injection ingestion and are an important tool for maintaining the health and productivity of sheep and goat herds.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Sheep and Goat Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sheep and Goat Vaccines.
The Sheep and Goat Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sheep and Goat Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sheep and Goat Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Sheep and Goat Vaccines Market Report

Report Metric Details
Report Name Sheep and Goat Vaccines Market
Accounted market size in year US$ 1151 million
Forecasted market size in 2031 US$ 1802 million
CAGR 6.7%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Sheep
  • Goat
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio, DHN, WINSUN, Elanco, Virbac
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Sheep and Goat Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Sheep and Goat Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Sheep and Goat Vaccines Market growing?

Ans: The Sheep and Goat Vaccines Market witnessing a CAGR of 6.7% during the forecast period 2025-2031.

What is the Sheep and Goat Vaccines Market size in 2031?

Ans: The Sheep and Goat Vaccines Market size in 2031 will be US$ 1802 million.

Who are the main players in the Sheep and Goat Vaccines Market report?

Ans: The main players in the Sheep and Goat Vaccines Market are Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio, DHN, WINSUN, Elanco, Virbac

What are the Application segmentation covered in the Sheep and Goat Vaccines Market report?

Ans: The Applications covered in the Sheep and Goat Vaccines Market report are Sheep, Goat

What are the Type segmentation covered in the Sheep and Goat Vaccines Market report?

Ans: The Types covered in the Sheep and Goat Vaccines Market report are Live Attenuated Vaccines, Inactivated Vaccines, Other

Recommended Reports

Animal Vaccine Markets

Vaccine Technologies

Disease-Specific Vaccines

1 Sheep and Goat Vaccines Market Overview
1.1 Product Definition
1.2 Sheep and Goat Vaccines by Type
1.2.1 Global Sheep and Goat Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 Live Attenuated Vaccines
1.2.3 Inactivated Vaccines
1.2.4 Other
1.3 Sheep and Goat Vaccines by Application
1.3.1 Global Sheep and Goat Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Sheep
1.3.3 Goat
1.4 Global Sheep and Goat Vaccines Market Size Estimates and Forecasts
1.4.1 Global Sheep and Goat Vaccines Revenue 2020-2031
1.4.2 Global Sheep and Goat Vaccines Sales 2020-2031
1.4.3 Global Sheep and Goat Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Sheep and Goat Vaccines Market Competition by Manufacturers
2.1 Global Sheep and Goat Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Sheep and Goat Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Sheep and Goat Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Sheep and Goat Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Sheep and Goat Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Sheep and Goat Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Sheep and Goat Vaccines, Date of Enter into This Industry
2.8 Global Sheep and Goat Vaccines Market Competitive Situation and Trends
2.8.1 Global Sheep and Goat Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Sheep and Goat Vaccines Players Market Share by Revenue
2.8.3 Global Sheep and Goat Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sheep and Goat Vaccines Market Scenario by Region
3.1 Global Sheep and Goat Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Sheep and Goat Vaccines Sales by Region: 2020-2031
3.2.1 Global Sheep and Goat Vaccines Sales by Region: 2020-2025
3.2.2 Global Sheep and Goat Vaccines Sales by Region: 2026-2031
3.3 Global Sheep and Goat Vaccines Revenue by Region: 2020-2031
3.3.1 Global Sheep and Goat Vaccines Revenue by Region: 2020-2025
3.3.2 Global Sheep and Goat Vaccines Revenue by Region: 2026-2031
3.4 North America Sheep and Goat Vaccines Market Facts & Figures by Country
3.4.1 North America Sheep and Goat Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Sheep and Goat Vaccines Sales by Country (2020-2031)
3.4.3 North America Sheep and Goat Vaccines Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sheep and Goat Vaccines Market Facts & Figures by Country
3.5.1 Europe Sheep and Goat Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Sheep and Goat Vaccines Sales by Country (2020-2031)
3.5.3 Europe Sheep and Goat Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sheep and Goat Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Sheep and Goat Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Sheep and Goat Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Sheep and Goat Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Sheep and Goat Vaccines Market Facts & Figures by Country
3.7.1 Latin America Sheep and Goat Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Sheep and Goat Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Sheep and Goat Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Sheep and Goat Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Sheep and Goat Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Sheep and Goat Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Sheep and Goat Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sheep and Goat Vaccines Sales by Type (2020-2031)
4.1.1 Global Sheep and Goat Vaccines Sales by Type (2020-2025)
4.1.2 Global Sheep and Goat Vaccines Sales by Type (2026-2031)
4.1.3 Global Sheep and Goat Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Sheep and Goat Vaccines Revenue by Type (2020-2031)
4.2.1 Global Sheep and Goat Vaccines Revenue by Type (2020-2025)
4.2.2 Global Sheep and Goat Vaccines Revenue by Type (2026-2031)
4.2.3 Global Sheep and Goat Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Sheep and Goat Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Sheep and Goat Vaccines Sales by Application (2020-2031)
5.1.1 Global Sheep and Goat Vaccines Sales by Application (2020-2025)
5.1.2 Global Sheep and Goat Vaccines Sales by Application (2026-2031)
5.1.3 Global Sheep and Goat Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Sheep and Goat Vaccines Revenue by Application (2020-2031)
5.2.1 Global Sheep and Goat Vaccines Revenue by Application (2020-2025)
5.2.2 Global Sheep and Goat Vaccines Revenue by Application (2026-2031)
5.2.3 Global Sheep and Goat Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Sheep and Goat Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Sheep and Goat Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Sheep and Goat Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Zoetis
6.2.1 Zoetis Company Information
6.2.2 Zoetis Description and Business Overview
6.2.3 Zoetis Sheep and Goat Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Zoetis Sheep and Goat Vaccines Product Portfolio
6.2.5 Zoetis Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Company Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Sheep and Goat Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Boehringer Ingelheim Sheep and Goat Vaccines Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Ceva
6.4.1 Ceva Company Information
6.4.2 Ceva Description and Business Overview
6.4.3 Ceva Sheep and Goat Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Ceva Sheep and Goat Vaccines Product Portfolio
6.4.5 Ceva Recent Developments/Updates
6.5 CAHIC
6.5.1 CAHIC Company Information
6.5.2 CAHIC Description and Business Overview
6.5.3 CAHIC Sheep and Goat Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 CAHIC Sheep and Goat Vaccines Product Portfolio
6.5.5 CAHIC Recent Developments/Updates
6.6 HVRI
6.6.1 HVRI Company Information
6.6.2 HVRI Description and Business Overview
6.6.3 HVRI Sheep and Goat Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 HVRI Sheep and Goat Vaccines Product Portfolio
6.6.5 HVRI Recent Developments/Updates
6.7 Ringpu Biology
6.7.1 Ringpu Biology Company Information
6.7.2 Ringpu Biology Description and Business Overview
6.7.3 Ringpu Biology Sheep and Goat Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Ringpu Biology Sheep and Goat Vaccines Product Portfolio
6.7.5 Ringpu Biology Recent Developments/Updates
6.8 Yebio
6.8.1 Yebio Company Information
6.8.2 Yebio Description and Business Overview
6.8.3 Yebio Sheep and Goat Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Yebio Sheep and Goat Vaccines Product Portfolio
6.8.5 Yebio Recent Developments/Updates
6.9 DHN
6.9.1 DHN Company Information
6.9.2 DHN Description and Business Overview
6.9.3 DHN Sheep and Goat Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.9.4 DHN Sheep and Goat Vaccines Product Portfolio
6.9.5 DHN Recent Developments/Updates
6.10 WINSUN
6.10.1 WINSUN Company Information
6.10.2 WINSUN Description and Business Overview
6.10.3 WINSUN Sheep and Goat Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.10.4 WINSUN Sheep and Goat Vaccines Product Portfolio
6.10.5 WINSUN Recent Developments/Updates
6.11 Elanco
6.11.1 Elanco Company Information
6.11.2 Elanco Description and Business Overview
6.11.3 Elanco Sheep and Goat Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Elanco Sheep and Goat Vaccines Product Portfolio
6.11.5 Elanco Recent Developments/Updates
6.12 Virbac
6.12.1 Virbac Company Information
6.12.2 Virbac Description and Business Overview
6.12.3 Virbac Sheep and Goat Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Virbac Sheep and Goat Vaccines Product Portfolio
6.12.5 Virbac Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sheep and Goat Vaccines Industry Chain Analysis
7.2 Sheep and Goat Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sheep and Goat Vaccines Production Mode & Process Analysis
7.4 Sheep and Goat Vaccines Sales and Marketing
7.4.1 Sheep and Goat Vaccines Sales Channels
7.4.2 Sheep and Goat Vaccines Distributors
7.5 Sheep and Goat Vaccines Customer Analysis
8 Sheep and Goat Vaccines Market Dynamics
8.1 Sheep and Goat Vaccines Industry Trends
8.2 Sheep and Goat Vaccines Market Drivers
8.3 Sheep and Goat Vaccines Market Challenges
8.4 Sheep and Goat Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Sheep and Goat Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Sheep and Goat Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Sheep and Goat Vaccines Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Sheep and Goat Vaccines Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Sheep and Goat Vaccines Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Sheep and Goat Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Sheep and Goat Vaccines Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Sheep and Goat Vaccines Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Sheep and Goat Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Sheep and Goat Vaccines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Sheep and Goat Vaccines, Product Type & Application
 Table 12. Global Key Manufacturers of Sheep and Goat Vaccines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Sheep and Goat Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sheep and Goat Vaccines as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Sheep and Goat Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Sheep and Goat Vaccines Sales by Region (2020-2025) & (K Units)
 Table 18. Global Sheep and Goat Vaccines Sales Market Share by Region (2020-2025)
 Table 19. Global Sheep and Goat Vaccines Sales by Region (2026-2031) & (K Units)
 Table 20. Global Sheep and Goat Vaccines Sales Market Share by Region (2026-2031)
 Table 21. Global Sheep and Goat Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Sheep and Goat Vaccines Revenue Market Share by Region (2020-2025)
 Table 23. Global Sheep and Goat Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Sheep and Goat Vaccines Revenue Market Share by Region (2026-2031)
 Table 25. North America Sheep and Goat Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Sheep and Goat Vaccines Sales by Country (2020-2025) & (K Units)
 Table 27. North America Sheep and Goat Vaccines Sales by Country (2026-2031) & (K Units)
 Table 28. North America Sheep and Goat Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Sheep and Goat Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Sheep and Goat Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Sheep and Goat Vaccines Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Sheep and Goat Vaccines Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Sheep and Goat Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Sheep and Goat Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Sheep and Goat Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Sheep and Goat Vaccines Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Sheep and Goat Vaccines Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Sheep and Goat Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Sheep and Goat Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Sheep and Goat Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Sheep and Goat Vaccines Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Sheep and Goat Vaccines Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Sheep and Goat Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Sheep and Goat Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Sheep and Goat Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Sheep and Goat Vaccines Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Sheep and Goat Vaccines Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Sheep and Goat Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Sheep and Goat Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Sheep and Goat Vaccines Sales (K Units) by Type (2020-2025)
 Table 51. Global Sheep and Goat Vaccines Sales (K Units) by Type (2026-2031)
 Table 52. Global Sheep and Goat Vaccines Sales Market Share by Type (2020-2025)
 Table 53. Global Sheep and Goat Vaccines Sales Market Share by Type (2026-2031)
 Table 54. Global Sheep and Goat Vaccines Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Sheep and Goat Vaccines Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Sheep and Goat Vaccines Revenue Market Share by Type (2020-2025)
 Table 57. Global Sheep and Goat Vaccines Revenue Market Share by Type (2026-2031)
 Table 58. Global Sheep and Goat Vaccines Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Sheep and Goat Vaccines Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Sheep and Goat Vaccines Sales (K Units) by Application (2020-2025)
 Table 61. Global Sheep and Goat Vaccines Sales (K Units) by Application (2026-2031)
 Table 62. Global Sheep and Goat Vaccines Sales Market Share by Application (2020-2025)
 Table 63. Global Sheep and Goat Vaccines Sales Market Share by Application (2026-2031)
 Table 64. Global Sheep and Goat Vaccines Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Sheep and Goat Vaccines Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Sheep and Goat Vaccines Revenue Market Share by Application (2020-2025)
 Table 67. Global Sheep and Goat Vaccines Revenue Market Share by Application (2026-2031)
 Table 68. Global Sheep and Goat Vaccines Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Sheep and Goat Vaccines Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Sheep and Goat Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck Sheep and Goat Vaccines Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Zoetis Company Information
 Table 76. Zoetis Description and Business Overview
 Table 77. Zoetis Sheep and Goat Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Zoetis Sheep and Goat Vaccines Product
 Table 79. Zoetis Recent Developments/Updates
 Table 80. Boehringer Ingelheim Company Information
 Table 81. Boehringer Ingelheim Description and Business Overview
 Table 82. Boehringer Ingelheim Sheep and Goat Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Boehringer Ingelheim Sheep and Goat Vaccines Product
 Table 84. Boehringer Ingelheim Recent Developments/Updates
 Table 85. Ceva Company Information
 Table 86. Ceva Description and Business Overview
 Table 87. Ceva Sheep and Goat Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Ceva Sheep and Goat Vaccines Product
 Table 89. Ceva Recent Developments/Updates
 Table 90. CAHIC Company Information
 Table 91. CAHIC Description and Business Overview
 Table 92. CAHIC Sheep and Goat Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. CAHIC Sheep and Goat Vaccines Product
 Table 94. CAHIC Recent Developments/Updates
 Table 95. HVRI Company Information
 Table 96. HVRI Description and Business Overview
 Table 97. HVRI Sheep and Goat Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. HVRI Sheep and Goat Vaccines Product
 Table 99. HVRI Recent Developments/Updates
 Table 100. Ringpu Biology Company Information
 Table 101. Ringpu Biology Description and Business Overview
 Table 102. Ringpu Biology Sheep and Goat Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Ringpu Biology Sheep and Goat Vaccines Product
 Table 104. Ringpu Biology Recent Developments/Updates
 Table 105. Yebio Company Information
 Table 106. Yebio Description and Business Overview
 Table 107. Yebio Sheep and Goat Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Yebio Sheep and Goat Vaccines Product
 Table 109. Yebio Recent Developments/Updates
 Table 110. DHN Company Information
 Table 111. DHN Description and Business Overview
 Table 112. DHN Sheep and Goat Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. DHN Sheep and Goat Vaccines Product
 Table 114. DHN Recent Developments/Updates
 Table 115. WINSUN Company Information
 Table 116. WINSUN Description and Business Overview
 Table 117. WINSUN Sheep and Goat Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. WINSUN Sheep and Goat Vaccines Product
 Table 119. WINSUN Recent Developments/Updates
 Table 120. Elanco Company Information
 Table 121. Elanco Description and Business Overview
 Table 122. Elanco Sheep and Goat Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Elanco Sheep and Goat Vaccines Product
 Table 124. Elanco Recent Developments/Updates
 Table 125. Virbac Company Information
 Table 126. Virbac Description and Business Overview
 Table 127. Virbac Sheep and Goat Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Virbac Sheep and Goat Vaccines Product
 Table 129. Virbac Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Sheep and Goat Vaccines Distributors List
 Table 133. Sheep and Goat Vaccines Customers List
 Table 134. Sheep and Goat Vaccines Market Trends
 Table 135. Sheep and Goat Vaccines Market Drivers
 Table 136. Sheep and Goat Vaccines Market Challenges
 Table 137. Sheep and Goat Vaccines Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Sheep and Goat Vaccines
 Figure 2. Global Sheep and Goat Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Sheep and Goat Vaccines Market Share by Type: 2024 & 2031
 Figure 4. Live Attenuated Vaccines Product Picture
 Figure 5. Inactivated Vaccines Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Sheep and Goat Vaccines Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Sheep and Goat Vaccines Market Share by Application: 2024 & 2031
 Figure 9. Sheep
 Figure 10. Goat
 Figure 11. Global Sheep and Goat Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Sheep and Goat Vaccines Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Sheep and Goat Vaccines Sales (2020-2031) & (K Units)
 Figure 14. Global Sheep and Goat Vaccines Average Price (US$/Unit) & (2020-2031)
 Figure 15. Sheep and Goat Vaccines Report Years Considered
 Figure 16. Sheep and Goat Vaccines Sales Share by Manufacturers in 2024
 Figure 17. Global Sheep and Goat Vaccines Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Sheep and Goat Vaccines Players: Market Share by Revenue in Sheep and Goat Vaccines in 2024
 Figure 19. Sheep and Goat Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Sheep and Goat Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Sheep and Goat Vaccines Sales Market Share by Country (2020-2031)
 Figure 22. North America Sheep and Goat Vaccines Revenue Market Share by Country (2020-2031)
 Figure 23. United States Sheep and Goat Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Sheep and Goat Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Sheep and Goat Vaccines Sales Market Share by Country (2020-2031)
 Figure 26. Europe Sheep and Goat Vaccines Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Sheep and Goat Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Sheep and Goat Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Sheep and Goat Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Sheep and Goat Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Sheep and Goat Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Sheep and Goat Vaccines Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Sheep and Goat Vaccines Revenue Market Share by Region (2020-2031)
 Figure 34. China Sheep and Goat Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Sheep and Goat Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Sheep and Goat Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Sheep and Goat Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Sheep and Goat Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Sheep and Goat Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Sheep and Goat Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Sheep and Goat Vaccines Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Sheep and Goat Vaccines Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Sheep and Goat Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Sheep and Goat Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Sheep and Goat Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Sheep and Goat Vaccines Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Sheep and Goat Vaccines Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Sheep and Goat Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Sheep and Goat Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Sheep and Goat Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Sheep and Goat Vaccines by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Sheep and Goat Vaccines by Type (2020-2031)
 Figure 53. Global Sheep and Goat Vaccines Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Sheep and Goat Vaccines by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Sheep and Goat Vaccines by Application (2020-2031)
 Figure 56. Global Sheep and Goat Vaccines Price (US$/Unit) by Application (2020-2031)
 Figure 57. Sheep and Goat Vaccines Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS